CSI Market
Sign In | Register

Kiniksa Pharmaceuticals International Plc (KNSA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KNSA Annual Balance Sheets →
Examining balance sheet movements between Kiniksa Pharmaceuticals International Plc and Sep 30 2025 reveals how Sep 30 2026 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/KNSA/balance-sheets
https://api.csimarket.com/api/v1/companies/KNSA/fundamentals
https://api.csimarket.com/api/v1/companies/KNSA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent81.66
Short-term Investments, Total0.00
Cash & Short-term Investments81.00
Accounts receivable30.78
Inventories108.03
Prepaid Expense And Other Assets Current42.53
Total Current Assets750.10
Equipment/Property/Plant Net9.98
Intangible Assets14.50
Other Assets, Noncurrent695.76
Deferred Income Tax Assets Net193.63
Total Assets983.24
Liabilities
Accounts Payable, Current AC4.11
Accrued Liabilities, Current AC57.70
Other Liabilities, Current130.05
Total Current Liabilities191.86
Total Long-term Debt0.00
Other liabilities, Noncurrent81.20
Operating Lease Liability Current75.58
Operating Lease Liability Noncurrent5.86
Total Liabilities273.05
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,079.69
Retained Earnings / Accumulated Deficit-366.77
Accumulated Other Comprehensive Income-2.75
Other Equity-2.75
Common Stockholder's Equity710.19
Total Stockholder's Equity710.19
Liabilities & Stockholder's Equity983.24
4 historic quarters locked

Sign in to unlock the full Kiniksa Pharmaceuticals International Plc balance sheet history.

Sign In Create Free Account

About Kiniksa Pharmaceuticals International Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-119186

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI